WHO ICTRP trial
Multicenter clinical study on precision treatment of biliary tract carcinoma
ChiCTR2000036960 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000036960 |
|---|---|
| Public title | Multicenter clinical study on precision treatment of biliary tract carcinoma |
| Scientific title | Multicenter clinical study on precision treatment of biliary tract carcinoma |
| Primary sponsor | Renji Hospital, Shanghai Jiaotong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | biliary tract carcinoma |
| Interventions | single arm treatment group:SHR1701 combined with GEMOX |
| Registration date | Aug 25, 2020 |
| Target size | single arm treatment group:76 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: